Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2012
12/20/2012US20120323016 Method of preparing derivatives/oligomers of epicatechin and applications thereof
12/20/2012US20120323011 Process and intermediate compounds useful in the preparation of statins
12/20/2012US20120323005 Process For The Preparation Of Amide Intermediates And Their Use Thereof
12/20/2012US20120323003 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
12/20/2012US20120322808 Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
12/20/2012US20120322803 Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322797 Selective beta-glucuronidase inhibitors as a treatment for side effects of camptothecin antineoplastic agents
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322787 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/20/2012US20120322785 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
12/20/2012US20120322784 Compounds, pharmaceutical compositions and uses thereof
12/20/2012US20120322755 Cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
12/20/2012US20120319091 Aromatic amine derivative, and organic electroluminescent element comprising same
12/20/2012CA2839675A1 Therapeutically active compositions and their methods of use
12/20/2012CA2818907A1 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
12/19/2012EP2535331A1 Condensed-Cyclic Compound and Organic Light-Emitting Diode Comprising the Same
12/19/2012EP2535329A2 Spiro-piperidine derivatives
12/19/2012EP2533780A1 5-ht4 receptor agonists for the treatment of dementia
12/19/2012EP2533640A1 Processes of synthesizing dihydropyridophthalazinone derivatives
12/19/2012CN102834391A Pyridazine compounds for controlling invertebrate pests
12/19/2012CN102834390A Novel diazinylpyrazolyl compounds
12/19/2012CN102834383A Cysteine protease inhibitors
12/19/2012CN102827893A Ester exchange method synthesizing process of aryl acetic acid (propionic acid) L-ascorbic acid ester
12/19/2012CN102827368A Biomass-based organic polymer porous material and synthesizing method thereof
12/19/2012CN102827170A Active treatment compositions and use method thereof
12/19/2012CN102827151A 7-methoxy-2, 8-bis (3-methylbut-2-enyl) xanthone-1, 3, 6-triyl tripyrazine-2-carboxylate, and semi-synthesis method and medicinal application thereof
12/19/2012CN102827132A Alpha-mangostin amino-acid ester derivative, as well as preparation method and application thereof
12/19/2012CN102827124A Coumarins derivate and medicine composition thereof and application
12/19/2012CN102827082A Thienopyrazole derivative having PDE7 inhibitory activity
12/19/2012CN102827078A Condensed-cyclic compound and organic light-emitting diode comprising the same
12/19/2012CN102827073A Therapeutically active compositions and application methods thereof
12/19/2012CN101115728B Triazole substituted aminobenzophenone compounds
12/19/2012CN101068794B Quinazolines useful as modulators of ion channels
12/18/2012US8334313 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
12/18/2012US8334304 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012US8334236 Ring-fused 2-pyridone derivatives and herbicides
12/18/2012CA2683956C Quinolones and azaquinolones that inhibit prolyl hydroxylase
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2577758C Gyrase inhibitors and uses thereof
12/13/2012WO2012170867A1 Novel compounds as modulators of gpr-119
12/13/2012WO2012170561A1 N-benzylindole modulators of pparg
12/13/2012WO2012169821A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
12/13/2012WO2012169579A1 Heterocyclic carboxylic acid ester derivative
12/13/2012WO2012169559A1 Azole derivative, method for producing azole derivative, and intermediate compound
12/13/2012WO2012169555A1 Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound
12/13/2012WO2012169516A1 Azole derivative, method for producing same, intermediate compound, and agricultural or horticultural chemical agent and industrial material protecting agent
12/13/2012WO2012168710A1 Hydantoin derivates as kv3 inhibitors
12/13/2012WO2012168350A1 Pyridin- 2 -amides useful as cb2 agonists
12/13/2012WO2012168226A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012US20120316313 Halogen-free flame retarding materials based on bisphenol triazole resins and polymers
12/13/2012US20120316201 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/13/2012US20120316199 Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
12/13/2012US20120316198 Hydrazone and diacyl hydrazine compounds and methods of use
12/13/2012US20120316197 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
12/13/2012US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors
12/13/2012US20120316193 Proteostasis regulators
12/13/2012US20120316182 Compounds that modulate intracellular calcium
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/13/2012US20120316168 Quinolone compound and pharmaceutical composition
12/13/2012US20120316167 Secondary 8-hydroxyquinoline-7-carboxamide derivatives
12/13/2012US20120316155 Imidazole-2,4-Dione Inhibitors of Casein Kinase 1
12/13/2012US20120316151 Triazolones as fatty acid synthase inhibitors
12/13/2012US20120316150 Amide compounds useful in therapy
12/13/2012US20120316147 Novel pyridine derivatives
12/13/2012US20120315217 Inverse agonists and neutral antagonists for the tsh receptor
12/13/2012CA2838586A1 Azole derivative, method for producing same, intermediate compound, and agricultural or horticultural chemical agent and industrial material protecting agent
12/13/2012CA2838435A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
12/13/2012CA2836487A1 Novel compounds as modulators of gpr-119
12/13/2012CA2835745A1 Pyridin - 2 - amides useful as cb2 agonists
12/12/2012EP2532660A1 Synthetic intermediates prepared using a 2-deoxyribose-5-phosphate aldolase (DERA) chemoenzymatic process
12/12/2012EP2532657A2 Compounds and methods of use
12/12/2012EP2532650A2 Modulators of ATP-binding cassette transporters
12/12/2012EP2531492A1 1,2,4-triazine-4-amine derivatives
12/12/2012EP2531490A1 Cyclohexyl amide derivatives as crf receptor antagonists
12/12/2012EP2531190A1 Tetrahydro-pyran derivatives against neurological illnesses
12/12/2012CN102823016A Material for organic electroluminescence element, and organic electroluminescence element using same
12/12/2012CN102823015A Material for organic electroluminescence element, and organic electroluminescence element using same
12/12/2012CN102822154A Heteroarylcarboxylic acid ester derivative
12/12/2012CN102822150A 1,2,4-triazine-4-amine derivatives
12/12/2012CN102816154A Amorphous state monohydrate (-)-doxazosin mesylate and preparation method and application thereof
12/12/2012CN102816153A Method for synthesizing vitamin E (VE) nicotinate
12/12/2012CN102816152A Method for preparing rosuvastatin intermediate
12/12/2012CN102070620B Preparation method of antibacterial ester
12/12/2012CN101809001B 咪唑衍生物 Imidazole derivatives
12/12/2012CN101500994B 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
12/12/2012CN101331119B Benzoylpyrazole compounds and herbicides containing them
12/11/2012US8329928 Compounds, compositions and methods
12/11/2012US8329922 Crystalline sodium atorvastatin
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329737 Benzimidazoles as selective kinase inhibitors
12/11/2012CA2648852C Fused phenyl amido heterocyclic compounds for the prevention and treatment of glucokinase-mediated diseases
12/11/2012CA2647819C Phenylcyclohexyl derivatives as dgat1 inhibitors
12/11/2012CA2570942C Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicament
12/11/2012CA2565237C Quinoxaline inhibitors of hedgehog signalling
12/11/2012CA2541928C Method for the production of amino crotonyl compounds
12/06/2012WO2012166387A1 Neprilysin inhibitors
12/06/2012WO2012165844A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
12/06/2012WO2012165832A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 694